More Articles

Patients and Medical

Asking The Big Questions

Adam Chapman, (Sep 13, 2017)

Pharma’s shift towards preventative care reflects its wider role within the healthcare system, says Anne Beal, Global Head of Patient Solutions, Sanofi.
Access and Evidence

Indication-Based Pricing: A Utopian Ideal?

Adam Chapman, (Sep 11, 2017)

The potential benefits of moving to a variable pricing model based on indication are manifold, but is the US healthcare system ready?
Commercial

An Atypical Patient Advocate

Danielle Barron, (Sep 11, 2017)

Merck EVP Dr. Julie Gerberding has not followed a classic professional path, either for a physician or a pharma executive. Instead, her unique career has been guided by a simple compass – the needs of patients
Commercial

Ipsen: Making Patient-Centricity A Reality

Lucy Fulford, (Sep 6, 2017)

The secret to embedding patient-centricity deep in an organization is to encourage colleagues to roll up their sleeves. After all, practice makes perfect, says Ipsen Chief Patient Affairs Officer
Patients and Medical

Pharma’s social contract: time for everyone to join in

Paul Simms, (Sep 6, 2017)

One year on, Brent Saunders of Allergan suggests to Paul Simms the case for expanding the pharma-patient social contract across the industry
Access and Evidence

Thinking Outside The Box

Adam Chapman, (Sep 5, 2017)

In digital, it’s all about personalization. Isn’t it time pharma caught up with other industries?
Access and Evidence

Finding Common Ground: Australian Government Seeks Closer Ties With Pharma

Adam Chapman, (Aug 30, 2017)

The Australian government asks for pharma’s help to ensure patients gain fast access to new medicines
Commercial

Patient-Centricity: Decoding The Buzzword

Adam Chapman, (Aug 24, 2017)

No matter how you slice it, pharma companies across the industry are scrambling to be perceived as putting the patient first. But who is making good on this? What more needs to be done?
Access and Evidence

Big Data, Huge Opportunity

Nancy Bergquist, (Aug 22, 2017)

Insights derived from big data are transforming the healthcare landscape, offering marketers a high-definition view of the patient and customer
Commercial

An Unexpected Journey

Des Sampson, (Aug 21, 2017)

A better understanding of the patient journey is increasingly informing company strategy

Pages